
Comprehensive Guide to Japan’s CDMO/CMO Landscape
10 - 11 September 2025 | Sheraton Towers Singapore
Japan is a global leader in pharmaceutical innovation, home to a robust network of Contract Development and Manufacturing Organizations (CDMOs) and Contract Manufacturing Organizations (CMOs). This guide provides a detailed list of key players in Japan’s CDMO/CMO sector, providing critical insights for biotechs, pharma and investors navigating Asia’s outsourcing landscape.

*This is not an exhaustive list. Some organisations may be omitted due to the evolving nature of the sector and reliance on publicly available sources.
For deeper engagement, join us at BCDMOA 2025 in Singapore, where collaboration and innovation shape the future of biologics manufacturing.
BIOLOGICS CDMO ASIA 2025

Asia's Premier Event Exclusively for CDMO's!
📍Sheraton Towers Singapore 📆 10 - 11 September 2025
The 4th Biologics CDMO Asia 2025 is a prominent event that brings together key leaders in the contract manufacturing sector to exchange successful case studies, address challenges and opportunities, and explore potential partnerships. It is also the only conference in the region that is exclusively focused on Contract Manufacturing in the APAC region.
350+ Attendees
180+ Organisations
40+ Expert Speakers
2025 SPEAKERS

Christopher Pawlak
External Manufacturing Lead, Bayer, Switzerland

Daniel Hurni
Former Director Manufacturing Network Strategy and Business Intelligence, Bristol Myers Squibb, Switzerland

Hu Jun
Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, Singapore

Sudeep Srivastava
Senior Vice President, Biological E. Limited, India

Jimmy Chang
CEO, TaiMed Biologics, Taiwan

Julio Lin
Vice President, Blue Blood Biotech, Taiwan

Jennifer Kuan
VP of Taiwan Operations, Bora Biologics, Taiwan

Kamyar Sadri
Former Regional Digital, Data & IT Lead, South East Asia, Novo Nordisk, Singapore

Warren Chan
Dean of the College of Engineering, Nanyang Technological University (NTU), Singapore

Lucas Chan
Visiting Senior Investigator and Advisor, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Bi Xuezhi
Senior Principal Scientist I & Group Leader, Protein Analytics, A*STAR Bioprocessing Technology Institute (BTI), Singapore

Andy Tan
Principal Scientist and Group Leader, Immune Cell Manufacturing, A*STAR Bioprocessing Technology Institute (BTI), Singapore

Zach Pang
Group Leader, Analytical Science & Technology (Bioprocess Data Integration), A*STAR Bioprocessing Technology Institute (BTI), Singapore

Akhil Prakash Chincholikar
Head R&D Project Management, Naprod Life Sciences, India

Share With Your Network
